Tremfya 200 mg/20 ml

Tremfya 200 mg/20 ml is a medicine authorised by Swissmedic under authorisation number 69974. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 June 2025 and the authorisation is limited until 09 June 2030. ATC code L04AC16 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 69974
  • ATC L04AC16
  • Biotechnological medicines
Authorisation data
Authorisation number69974
NameTremfya 200 mg/20 ml
Full nameTremfya 200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderJanssen-Cilag AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeL04AC16
First authorisation10 June 2025
Authorisation validity09 June 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Tremfya 200 mg/20 ml, Konzentrat zur Herstellung einer InfusionslösungB10 June 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L04AC1607.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Tremfya 200 mg/20 ml authorised in Switzerland?

Yes. Tremfya 200 mg/20 ml is authorised by Swissmedic under authorisation number 69974, data as of 01 September 2026. The authorisation is limited until 09 June 2030.

Which dispensing category does Tremfya 200 mg/20 ml have?

Tremfya 200 mg/20 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Tremfya 200 mg/20 ml?

The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com